Guizhou Sanli Pharmaceutical Co., Ltd. Class ASSE: 603439

Announcement on the Holding of 2025 Collective Reception Day for Investors of Listed Companies in Guizhou Jurisdiction and 2024 Annual Performance Briefing

· Issued by Guizhou Sanli Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Holding of 2025 Collective Reception Day for Investors of Listed Companies in Guizhou Jurisdiction and 2024 Annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis